Skip to content

Efficacy of Guggulu Marichadi taila (Topical) along with Rasamanikya (Oral) versus Rasamanikya (Oral) alone in the management of Psoriasis w.s.r. to Eka Kushta

A Randomized Controlled Clinical Study to evaluate the efficacy of Guggulu Marichadi taila (Topical) along with Rasamanikya (Oral) versus Rasamanikya (Oral) alone in the management of Psoriasis w.s.r. to Eka Kushta - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/101059
Enrollment
120
Registered
2026-01-14
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L409- Psoriasis, unspecified

Interventions

None listed

Sponsors

Dr. Ashish Dubey
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subjects with classical lakshana of eka kushta(Psoriasis) and clinical features of Psoriasis such as absence of sweating, extensive localization, resembling the scales of fish. 2. Subjects of either sex between the age group of 18 and 60 years. 3. Subjects with duration of upto 5 years will be selected. 4. Subjects with positive Auspitz sign.

Exclusion criteria

Exclusion criteria: 1. Subjects with uncontrolled metabolic disorders like hypothyroidism, hyperthyroidism , DM . 2. Subjects with other systemic disorders like Epilepsy , Kochs , HIV , etc. 3. Eka kushta ( Psoriasis ) with extracutaneous manifestations.

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy of Guggulu Marichadi Taila along with Rasamanikya in the management of Psoriasis w.s.r. to Eka KushtaTimepoint: 2 months

Secondary

MeasureTime frame
To compare the the efficacy of Guggulu Marichadi Taila along with Rasamanikya and Rasamanikya alone in the management of Psoriasis w.s.r. to Eka KushtaTimepoint: 2 months;To determine the combined efficacy of Rasamanikya and Guggulu Marichadi Taila in comparison to control.Timepoint: 2 months;To observe and document any adverse effect or complications arising from the intervention during the study period.Timepoint: 2 months

Countries

India

Contacts

Public ContactDr Ashish H Mhatre

Padmashree Dr DY Patil Deemed to be University , School of Ayurveda.

ashish.mhatre@dypatil.edu9819639895

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026